Gan & Lee Pharmaceuticals. (SHA:603087)
63.51
-0.59 (-0.92%)
Nov 17, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 37.81 billion as of November 17, 2026. It is the 3,188th most valuable company in the world and the 375th biggest in China. Its market cap has decreased by 5.54% in one year.
Market Cap
37.81B
Enterprise Value
33.59B
Revenue
4.37B
Global Rank
Country Rank
#375 China
PE Ratio
31.75
ChartMarket Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 37.81B, an increase of 3.38%. That is a compound annual growth rate of 0.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 37.81B | -6.68% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intco Medical Technology | 28.89B |
| Imeik Technology Development | 25.79B |
| iRay Group | 23.56B |
| Andon Health | 23.25B |
| Zhende Medical | 22.03B |
| Winner Medical | 16.78B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.77B |
| Jiangsu Hualan New Pharmaceutical Material | 10.33B |